Pharmaceutical industry – Page 47

Business
US blocks imports from fourth Ranbaxy plant

2014-01-27T00:00:00Z

FDA bans import of active ingredients from factory in Toansa, India
Business
Novartis and DSM trim jobs

2014-01-24T00:00:00Z

Novartis to close US manufacturing site, both companies restructuring Swiss operations
News
Croatia's vaccines manufacturer left hanging as it enters administration

2014-01-22T00:00:00Z

Lack of government investment puts national immunology institute in crisis
News
Radical drug rule changes hit buffers in India

2014-01-15T00:00:00Z

Oversight panel concludes government plan will increase bureaucracy
Business
Novartis in the spotlight in mis-selling investigations

2014-01-09T00:00:00Z

Crackdown on pharma marketing continues with US and Japanese cases
Opinion
Is there a drug for that?

2014-01-07T00:00:00Z

Derek Lowe ponders whether anything is truly ‘undruggable’ if we look in the right places
Business
Weathering the storm

2014-01-06T00:00:00Z

Pharmaceutical industry roundup 2013
Business
Sanofi suffers multiple sclerosis setback

2014-01-03T00:00:00Z

US drug agency will not approve alemtuzumab
Business
AstraZeneca claims quashed in heartburn drug patent case

2013-12-23T00:00:00Z

Nexium rival does not infringe on patent, court rules
Business
Chinese police seize £222m of fake drugs

2013-12-20T00:00:00Z

1300 people are arrested in a nationwide crackdown on counterfeit medicines
Business
AstraZeneca shells out $4.1bn for diabetes business

2013-12-20T00:00:00Z

Bristol-Myers Squibb exits the diabetes field with plans to become a specialised biopharmaceutical company
Opinion
Cut price pills cost more than pennies

2013-12-19T00:00:00Z

We can’t afford to let the demand for cheaper medicines force compromises on quality, says Steven Ford
Business
Celgene buys into anticancer antibodies

2013-12-04T00:00:00Z

Partners with OncoMed in a deal worth up to $3.3bn
Business
New wave of hepatitis C drugs hits US shore

2013-12-03T00:00:00Z

J&J’s once-daily drug approved by FDA, but rivals are hot on its heels
Business
US turnaround on Avandia restrictions

2013-12-02T00:00:00Z

Researchers accuse regulator of face-saving U-turn over diabetes medication safety
Opinion
Put the chemistry back in medicinal chemistry

2013-11-28T00:00:00Z

Pursuing skewed priorities and easy options has impoverished the pharmaceutical industry, says David Lathbury.
Opinion
Rolling boulders uphill

2013-11-27T00:00:00Z

Is Derek Lowe troubled by his failure to develop a compound that has made it to the pharmacy shelf?
Business
Regulator cracks down on 23andMe

2013-11-26T00:00:00Z

Personal genetic profiler ordered to stop selling DNA test kits
Business
Pfizer teams up with GSK in cancer drug trial

2013-11-25T00:00:00Z

Two companies will collaborate to develop a combination therapy for melanoma
Feature
Generic problems

2013-11-22T00:00:00Z

The Indian pharmaceutical industry has been hit by recent problems. Angeli Mehta investigates